Impact of SARS-CoV-2 outbreak on heart and lung transplant: A patient-perspective survey.
David BennettElda De VitaVittoria VenturaSonia BernazzaliAntonella FossiPiero PaladiniLuca LuzziMassimo MaccheriniSerafina ValenteElena BargagliBruno FredianiPiersante SestiniPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2020)
In our study, we observed a low incidence of COVID-19 in heart and lung transplant patients (0.9%), similar to that of the general population of our Region. Isolation measures were already observed before the pandemic and were further strengthened in most cases. Particular attention should also be paid to new psychological and physical complications indirectly linked to the COVID-19 pandemic.
Keyphrases
- sars cov
- coronavirus disease
- end stage renal disease
- respiratory syndrome coronavirus
- heart failure
- chronic kidney disease
- risk factors
- ejection fraction
- newly diagnosed
- atrial fibrillation
- prognostic factors
- physical activity
- case report
- peritoneal dialysis
- cross sectional
- patient reported outcomes
- working memory
- mental health
- depressive symptoms